is glp 1 a miracle drug GLP-1s: or missed opportunity? Hims & Hers, and the

2 GLP-1R monotherapy (e.g., semaglutide) is highly effective, but dual GLP-1R/GIPR agonists (e.g., tirzepatide) deliver superior results

Secondly, there is a lack of uniformity in the efficacy evaluation methods employed across studies

Hospitals adoption of GLP-1 receptor agonists is driven by their ability to manage and treat diabetic patients with a variety of therapeutic options, from daily injections to newly available oral formulations

My Takeaway Thus Far At the end of the day, what matters most to me is seeing people win the fight against addiction

Turk J Med Sci (2015) 45(5):113740

Novo won't have this exclusive sales opportunity forever